Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total revenue, net		$ 80,167	$ 94,440	$ 166,142	$ 189,070
Less: Cost of goods sold		23,199	35,810	48,993	58,049
Less: Cost of goods sold - restructuring inventory		14,300	15,000	26,554	15,000
Gross margin		42,668	43,630	90,595	116,021
Operating expenses:
Selling, general and administrative		50,953	86,893	110,540	177,540
Research and development		5,642	9,356	11,323	19,407
Restructuring expenses		10,032	10,213	10,032	10,213
Total operating expenses		66,627	106,462	131,895	207,160
Operating loss		(23,959)	(62,832)	(41,300)	(91,139)
Interest income, net		3,001	288	5,222	491
Other income (expense), net		3,043	(2,255)	3,667	(2,501)
Loss from operations before taxes		(17,915)	(64,799)	(32,411)	(93,149)
Income tax benefit (provision)		355	(5,157)	(1,609)	(8,370)
Net loss		$ (17,560)	$ (69,956)	$ (34,020)	$ (101,519)
Loss per share:
Basic	[1]	$ (0.04)	$ (0.18)	$ (0.08)	$ (0.26)
Diluted	[1]	$ (0.04)	$ (0.18)	$ (0.08)	$ (0.26)
Weighted average shares:
Basic		407,848	398,187	407,017	397,997
Diluted		407,848	398,187	407,017	397,997
Product Revenue, Net
Total revenue, net		$ 65,187	$ 93,796	$ 149,841	$ 187,782
Licensing and Royalty Revenue
Total revenue, net		$ 14,980	$ 644	$ 16,301	$ 1,288

[1] Excluding the licensing revenue change in estimate, as discussed in Note 8 - Development, Commercialization and Supply Agreements, net loss per share basic and diluted for the three and six months ended June 30, 2023 would have been $(0.06) and $(0.10), respectively.